G.Boza-SerranoA.PaulusA.DenisQ.et al (2022)
Time period What may be noticeable What the evidence supports Weeks 1-4 Satiety, appetite changes, nausea, bowel changes, early scale movement Early tolerability period, not the main efficacy endpoint window Weeks 4-12 More consistent appetite suppression and early weight trend Direction of response may become clearer, but individual variance is high Weeks 12-24 Clinically meaningful separation becomes easier to evaluate Phase 2 primary endpoint at 24 weeks showed dose-dependent weight loss Weeks 24-48 Major body-weight reduction window in Phase 2 48-week Phase 2 secondary endpoint showed the largest published Phase 2 changes Weeks 68-104 Longer-term Phase 3 and extension outcomes TRIUMPH program endpoints measure durability over longer windows Weeks 1-4: Early Signals, Not Final Results The first few weeks are usually the wrong window for judging full retatrutide results
Consequently, the amount of free sugars rises significantly, contributing to the characteristic sweet flavor of black garlic [17]
Ethical Considerations: Ensure all research adheres to ethical guidelines, prioritizing safety and responsible scientific practice
Eur Heart J 27(19):23382345 Levitan EB, Wolk A, Mittleman MA (2009) Relation of consistency with the dietary approaches to stop hypertension diet and incidence of heart failure in men aged 45 to 79 years
Long-term treatment with Wegovy may be necessary to maintain weight loss results
